|
Sabater-Molina M, Saura D, García-Molina Sáez E, González-Carrillo J, Polo L, Pérez-Sánchez I, Olmo MDC, Oliva-Sandoval MJ, Barriales-Villa R, Carbonell P, Pascual-Figal D, Gimeno JR. A Novel Founder Mutation in MYBPC3: Phenotypic Comparison With the Most Prevalent MYBPC3 Mutation in Spain. Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):105-114. doi: 10.1016/j.rec.2016.06.020. Epub 2016 Oct 28. English, Spanish. PubMed PMID: 28029522.
AÑO: 2017; IF: 5.166
|
28029522
|
García-Solano J, García-Solano ME, Torres-Moreno D, Carbonell P, Trujillo-Santos J, Pérez-Guillermo M, Conesa-Zamora P. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas. Cell Oncol (Dordr). 2016 Jun;39(3):243-52. doi: 10.1007/s13402-016-0269-5. Epub 2016 Feb 1. PubMed PMID: 26832730.
AÑO: 2016; IF: 3.786
|
|
Ríos A, Rodríguez JM, Carbonel P, Parrilla P. [Selection criteria for search for germ mutations in colorectal cancer hereditary nonpolyposis]. Med Clin (Barc). 2015 Feb 20;144(4):185-6. doi: 10.1016/j.medcli.2014.09.006. Spanish. PubMed PMID: 25458510.
AÑO: 2015; IF: 1.267
|
|
Grasso S, Tristante E, Saceda M, Carbonell P, Mayor-López L, Carballo-Santana M, Carrasco-García E, Rocamora-Reverte L, García-Morales P, Carballo F, Ferragut JA, Martínez-Lacaci I. Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation. Neoplasia. 2014 Oct 23;16(10):845-60. doi: 10.1016/j.neo.2014.08.011. PubMed PMID: 25379021; PubMed Central PMCID: PMC4212257.
AÑO: 2014; IF: 4.252
|
|
García-Solano J, Conesa-Zamora P, Carbonell P, Trujillo-Santos J, Torres-Moreno D, Rodriguez-Braun E, Vicente-Ortega V, Pérez-Guillermo M. Microsatellite pathologic score does not efficiently identify high microsatellite instability in colorectal serrated adenocarcinoma. Hum Pathol. 2013 May;44(5):759-65. doi: 10.1016/j.humpath.2012.07.020. PubMed PMID: 23089493.
AÑO: 2013; IF: 2.74
|